RU2014125435A - Способ получения производных стерина - Google Patents
Способ получения производных стерина Download PDFInfo
- Publication number
- RU2014125435A RU2014125435A RU2014125435/04A RU2014125435A RU2014125435A RU 2014125435 A RU2014125435 A RU 2014125435A RU 2014125435/04 A RU2014125435/04 A RU 2014125435/04A RU 2014125435 A RU2014125435 A RU 2014125435A RU 2014125435 A RU2014125435 A RU 2014125435A
- Authority
- RU
- Russia
- Prior art keywords
- hydroxy
- acetoxy
- aminopropylamino
- formula
- integer
- Prior art date
Links
- 238000004519 manufacturing process Methods 0.000 title claims 7
- 229930193551 sterin Natural products 0.000 title 1
- 150000001875 compounds Chemical class 0.000 claims abstract 26
- 238000000034 method Methods 0.000 claims abstract 14
- 125000006239 protecting group Chemical group 0.000 claims abstract 14
- 239000012429 reaction media Substances 0.000 claims abstract 14
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 claims abstract 12
- SIKJAQJRHWYJAI-UHFFFAOYSA-N Indole Chemical group C1=CC=C2NC=CC2=C1 SIKJAQJRHWYJAI-UHFFFAOYSA-N 0.000 claims abstract 8
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 claims abstract 8
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 claims abstract 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract 4
- 125000002883 imidazolyl group Chemical group 0.000 claims abstract 4
- PZOUSPYUWWUPPK-UHFFFAOYSA-N indole Chemical group CC1=CC=CC2=C1C=CN2 PZOUSPYUWWUPPK-UHFFFAOYSA-N 0.000 claims abstract 4
- RKJUIXBNRJVNHR-UHFFFAOYSA-N indolenine Chemical group C1=CC=C2CC=NC2=C1 RKJUIXBNRJVNHR-UHFFFAOYSA-N 0.000 claims abstract 4
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims abstract 4
- 229920000768 polyamine Polymers 0.000 claims abstract 4
- 238000010992 reflux Methods 0.000 claims abstract 4
- 238000002955 isolation Methods 0.000 claims abstract 3
- 125000003668 acetyloxy group Chemical group [H]C([H])([H])C(=O)O[*] 0.000 claims abstract 2
- 125000004106 butoxy group Chemical group [*]OC([H])([H])C([H])([H])C(C([H])([H])[H])([H])[H] 0.000 claims abstract 2
- 125000004432 carbon atom Chemical group C* 0.000 claims abstract 2
- 239000000203 mixture Substances 0.000 claims abstract 2
- -1 4-aminobutylamino Chemical group 0.000 claims 45
- 125000000031 ethylamino group Chemical group [H]C([H])([H])C([H])([H])N([H])[*] 0.000 claims 21
- 125000006308 propyl amino group Chemical group 0.000 claims 16
- 125000006309 butyl amino group Chemical group 0.000 claims 15
- XIIAYQZJNBULGD-UHFFFAOYSA-N (5alpha)-cholestane Natural products C1CC2CCCCC2(C)C2C1C1CCC(C(C)CCCC(C)C)C1(C)CC2 XIIAYQZJNBULGD-UHFFFAOYSA-N 0.000 claims 9
- IZVFFXVYBHFIHY-UHFFFAOYSA-N (3alpha, 5alpha)-Cholest-7-en-3-ol, 9CI Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)CCCC(C)C)CCC33)C)C3=CCC21 IZVFFXVYBHFIHY-UHFFFAOYSA-N 0.000 claims 8
- 125000004042 4-aminobutyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])N([H])[H] 0.000 claims 8
- XIIAYQZJNBULGD-LDHZKLTISA-N cholestane Chemical compound C1CC2CCCC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 XIIAYQZJNBULGD-LDHZKLTISA-N 0.000 claims 8
- 125000000814 indol-3-yl group Chemical group [H]C1=C([H])C([H])=C2N([H])C([H])=C([*])C2=C1[H] 0.000 claims 8
- IZVFFXVYBHFIHY-SKCNUYALSA-N 5alpha-cholest-7-en-3beta-ol Chemical compound C1[C@@H](O)CC[C@]2(C)[C@@H](CC[C@@]3([C@@H]([C@H](C)CCCC(C)C)CC[C@H]33)C)C3=CC[C@H]21 IZVFFXVYBHFIHY-SKCNUYALSA-N 0.000 claims 7
- APXXTQNUGVCUBV-WUHSCZTQSA-N cholest-7-ene Chemical compound C1CCC[C@]2(C)[C@@H](CC[C@@]3([C@@H]([C@H](C)CCCC(C)C)CC[C@H]33)C)C3=CCC21 APXXTQNUGVCUBV-WUHSCZTQSA-N 0.000 claims 7
- QYIXCDOBOSTCEI-UHFFFAOYSA-N alpha-cholestanol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)CCCC(C)C)C1(C)CC2 QYIXCDOBOSTCEI-UHFFFAOYSA-N 0.000 claims 6
- QYIXCDOBOSTCEI-QCYZZNICSA-N (5alpha)-cholestan-3beta-ol Chemical compound C([C@@H]1CC2)[C@@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@H](C)CCCC(C)C)[C@@]2(C)CC1 QYIXCDOBOSTCEI-QCYZZNICSA-N 0.000 claims 5
- 125000002140 imidazol-4-yl group Chemical group [H]N1C([H])=NC([*])=C1[H] 0.000 claims 5
- NTYJJOPFIAHURM-UHFFFAOYSA-N Histamine Chemical compound NCCC1=CN=CN1 NTYJJOPFIAHURM-UHFFFAOYSA-N 0.000 claims 4
- ATHGHQPFGPMSJY-UHFFFAOYSA-N spermidine Chemical compound NCCCCNCCCN ATHGHQPFGPMSJY-UHFFFAOYSA-N 0.000 claims 4
- AVFNYTPENXWWCA-BULFVYHESA-N (3s,5r,6r,8s,9s,10r,13r,14s,17r)-6-[2-(1h-imidazol-5-yl)ethylamino]-10,13-dimethyl-17-[(2r)-6-methylheptan-2-yl]-1,2,3,4,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthrene-3,5-diol Chemical compound N([C@@H]1C[C@H]2[C@@H]3CC[C@@H]([C@]3(CC[C@@H]2[C@@]2(C)CC[C@H](O)C[C@@]21O)C)[C@H](C)CCCC(C)C)CCC1=CNC=N1 AVFNYTPENXWWCA-BULFVYHESA-N 0.000 claims 3
- 239000004593 Epoxy Substances 0.000 claims 3
- 150000001412 amines Chemical class 0.000 claims 3
- BTANRVKWQNVYAZ-UHFFFAOYSA-N butan-2-ol Chemical compound CCC(C)O BTANRVKWQNVYAZ-UHFFFAOYSA-N 0.000 claims 3
- HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 claims 2
- 239000003054 catalyst Substances 0.000 claims 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 claims 2
- 229960001340 histamine Drugs 0.000 claims 2
- KIDHWZJUCRJVML-UHFFFAOYSA-N putrescine Chemical compound NCCCCN KIDHWZJUCRJVML-UHFFFAOYSA-N 0.000 claims 2
- QZAYGJVTTNCVMB-UHFFFAOYSA-N serotonin Chemical compound C1=C(O)C=C2C(CCN)=CNC2=C1 QZAYGJVTTNCVMB-UHFFFAOYSA-N 0.000 claims 2
- 239000002904 solvent Substances 0.000 claims 2
- 229940063673 spermidine Drugs 0.000 claims 2
- PFNFFQXMRSDOHW-UHFFFAOYSA-N spermine Chemical compound NCCCNCCCCNCCCN PFNFFQXMRSDOHW-UHFFFAOYSA-N 0.000 claims 2
- XFNJVJPLKCPIBV-UHFFFAOYSA-N trimethylenediamine Chemical compound NCCCN XFNJVJPLKCPIBV-UHFFFAOYSA-N 0.000 claims 2
- APJYDQYYACXCRM-UHFFFAOYSA-N tryptamine Chemical compound C1=CC=C2C(CCN)=CNC2=C1 APJYDQYYACXCRM-UHFFFAOYSA-N 0.000 claims 2
- KZJWDPNRJALLNS-VPUBHVLGSA-N (-)-beta-Sitosterol Natural products O[C@@H]1CC=2[C@@](C)([C@@H]3[C@H]([C@H]4[C@@](C)([C@H]([C@H](CC[C@@H](C(C)C)CC)C)CC4)CC3)CC=2)CC1 KZJWDPNRJALLNS-VPUBHVLGSA-N 0.000 claims 1
- CSVWWLUMXNHWSU-UHFFFAOYSA-N (22E)-(24xi)-24-ethyl-5alpha-cholest-22-en-3beta-ol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)C=CC(CC)C(C)C)C1(C)CC2 CSVWWLUMXNHWSU-UHFFFAOYSA-N 0.000 claims 1
- JWAFAAMANYWGHR-VWTROAGRSA-N (3s,5r,6r,8s,9s,10r,13r,14s,17r)-6-(4-aminobutylamino)-10,13-dimethyl-17-[(2r)-6-methylheptan-2-yl]-1,2,3,4,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthrene-3,5-diol Chemical compound C([C@]1(O)[C@H](NCCCCN)C2)[C@@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@H](C)CCCC(C)C)[C@@]2(C)CC1 JWAFAAMANYWGHR-VWTROAGRSA-N 0.000 claims 1
- GBXABOGVYLCLLO-QQFOGAIFSA-N (3s,5r,6r,8s,9s,10r,13r,14s,17r)-6-[4-(3-aminopropylamino)butylamino]-10,13-dimethyl-17-[(2r)-6-methylheptan-2-yl]-1,2,3,4,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthrene-3,5-diol Chemical compound C([C@]1(O)[C@H](NCCCCNCCCN)C2)[C@@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@H](C)CCCC(C)C)[C@@]2(C)CC1 GBXABOGVYLCLLO-QQFOGAIFSA-N 0.000 claims 1
- BLYVUYZBUKXNDE-GDAXLBPBSA-N (3s,5r,6r,9s,10r,13r,14r,17r)-6-[3-(4-aminobutylamino)propylamino]-10,13-dimethyl-17-[(2r)-6-methylheptan-2-yl]-1,2,3,4,6,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthrene-3,5-diol Chemical compound C1[C@@H](O)CC[C@]2(C)[C@@H](CC[C@@]3([C@@H]([C@H](C)CCCC(C)C)CC[C@H]33)C)C3=C[C@@H](NCCCNCCCCN)[C@]21O BLYVUYZBUKXNDE-GDAXLBPBSA-N 0.000 claims 1
- KLEXDBGYSOIREE-UHFFFAOYSA-N 24xi-n-propylcholesterol Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CCC)C(C)C)C1(C)CC2 KLEXDBGYSOIREE-UHFFFAOYSA-N 0.000 claims 1
- NHQDETIJWKXCTC-UHFFFAOYSA-N 3-chloroperbenzoic acid Chemical compound OOC(=O)C1=CC=CC(Cl)=C1 NHQDETIJWKXCTC-UHFFFAOYSA-N 0.000 claims 1
- ZKQRGSXITBHHPC-CBTBQNHGSA-N Campesta-5,7-dien-3beta-ol Chemical compound C1[C@@H](O)CC[C@]2(C)C(CC[C@@]3([C@@H]([C@H](C)CC[C@@H](C)C(C)C)CC[C@H]33)C)C3=CC=C21 ZKQRGSXITBHHPC-CBTBQNHGSA-N 0.000 claims 1
- SGNBVLSWZMBQTH-FGAXOLDCSA-N Campesterol Natural products O[C@@H]1CC=2[C@@](C)([C@@H]3[C@H]([C@H]4[C@@](C)([C@H]([C@H](CC[C@H](C(C)C)C)C)CC4)CC3)CC=2)CC1 SGNBVLSWZMBQTH-FGAXOLDCSA-N 0.000 claims 1
- LPZCCMIISIBREI-MTFRKTCUSA-N Citrostadienol Natural products CC=C(CC[C@@H](C)[C@H]1CC[C@H]2C3=CC[C@H]4[C@H](C)[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C)C(C)C LPZCCMIISIBREI-MTFRKTCUSA-N 0.000 claims 1
- ARVGMISWLZPBCH-UHFFFAOYSA-N Dehydro-beta-sitosterol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)CCC(CC)C(C)C)CCC33)C)C3=CC=C21 ARVGMISWLZPBCH-UHFFFAOYSA-N 0.000 claims 1
- UCTLRSWJYQTBFZ-UHFFFAOYSA-N Dehydrocholesterol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)CCCC(C)C)CCC33)C)C3=CC=C21 UCTLRSWJYQTBFZ-UHFFFAOYSA-N 0.000 claims 1
- BTEISVKTSQLKST-UHFFFAOYSA-N Haliclonasterol Natural products CC(C=CC(C)C(C)(C)C)C1CCC2C3=CC=C4CC(O)CCC4(C)C3CCC12C BTEISVKTSQLKST-UHFFFAOYSA-N 0.000 claims 1
- 229910013684 LiClO 4 Inorganic materials 0.000 claims 1
- 239000005700 Putrescine Substances 0.000 claims 1
- 125000003277 amino group Chemical group 0.000 claims 1
- MJVXAPPOFPTTCA-UHFFFAOYSA-N beta-Sistosterol Natural products CCC(CCC(C)C1CCC2C3CC=C4C(C)C(O)CCC4(C)C3CCC12C)C(C)C MJVXAPPOFPTTCA-UHFFFAOYSA-N 0.000 claims 1
- LGJMUZUPVCAVPU-UHFFFAOYSA-N beta-Sitostanol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CC)C(C)C)C1(C)CC2 LGJMUZUPVCAVPU-UHFFFAOYSA-N 0.000 claims 1
- NJKOMDUNNDKEAI-UHFFFAOYSA-N beta-sitosterol Natural products CCC(CCC(C)C1CCC2(C)C3CC=C4CC(O)CCC4C3CCC12C)C(C)C NJKOMDUNNDKEAI-UHFFFAOYSA-N 0.000 claims 1
- QEXYQUPDUJHODW-UHFFFAOYSA-N butane-1,1,4-triamine Chemical compound NCCCC(N)N QEXYQUPDUJHODW-UHFFFAOYSA-N 0.000 claims 1
- SGNBVLSWZMBQTH-PODYLUTMSA-N campesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](C)C(C)C)[C@@]1(C)CC2 SGNBVLSWZMBQTH-PODYLUTMSA-N 0.000 claims 1
- 235000000431 campesterol Nutrition 0.000 claims 1
- 239000003153 chemical reaction reagent Substances 0.000 claims 1
- 235000012000 cholesterol Nutrition 0.000 claims 1
- 150000002118 epoxides Chemical class 0.000 claims 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims 1
- XNYADZUHUHIGRZ-UHFFFAOYSA-N propane-1,1,3-triamine Chemical compound NCCC(N)N XNYADZUHUHIGRZ-UHFFFAOYSA-N 0.000 claims 1
- 229940076279 serotonin Drugs 0.000 claims 1
- KZJWDPNRJALLNS-VJSFXXLFSA-N sitosterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](CC)C(C)C)[C@@]1(C)CC2 KZJWDPNRJALLNS-VJSFXXLFSA-N 0.000 claims 1
- 235000015500 sitosterol Nutrition 0.000 claims 1
- 229950005143 sitosterol Drugs 0.000 claims 1
- NLQLSVXGSXCXFE-UHFFFAOYSA-N sitosterol Natural products CC=C(/CCC(C)C1CC2C3=CCC4C(C)C(O)CCC4(C)C3CCC2(C)C1)C(C)C NLQLSVXGSXCXFE-UHFFFAOYSA-N 0.000 claims 1
- 229940063675 spermine Drugs 0.000 claims 1
- QYSXJUFSXHHAJI-YRZJJWOYSA-N vitamin D3 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C\C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-YRZJJWOYSA-N 0.000 claims 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
- C07J43/003—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
- C07J41/0005—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring the nitrogen atom being directly linked to the cyclopenta(a)hydro phenanthrene skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
- C07J71/0005—Oxygen-containing hetero ring
- C07J71/001—Oxiranes
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Steroid Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP11306548 | 2011-11-24 | ||
| EP11306548.6 | 2011-11-24 | ||
| PCT/EP2012/073489 WO2013076257A1 (en) | 2011-11-24 | 2012-11-23 | Process for the preparation of sterol derivatives |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| RU2014125435A true RU2014125435A (ru) | 2015-12-27 |
Family
ID=47216329
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2014125435/04A RU2014125435A (ru) | 2011-11-24 | 2012-11-23 | Способ получения производных стерина |
Country Status (14)
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2015106164A1 (en) | 2014-01-10 | 2015-07-16 | Rgenix, Inc. | Lxr agonists and uses thereof |
| JP7025022B2 (ja) | 2016-01-11 | 2022-02-24 | ザ ロックフェラー ユニバーシティー | 骨髄系由来抑制細胞関連障害の治療のための方法 |
| FR3064470A1 (fr) * | 2017-03-31 | 2018-10-05 | Lessonia | Masque ou patch prepare a partir d’une composition d’alginate |
| JP2021504315A (ja) | 2017-11-21 | 2021-02-15 | ルジェニクス，インコーポレーテッド | 多形及びその使用 |
| EP3852765A4 (en) * | 2018-09-19 | 2022-06-22 | ModernaTX, Inc. | PURIFICATION OF STEROL |
| BE1027157B9 (fr) * | 2019-08-01 | 2020-11-03 | Dendrogenix | Composition de dérivés de stérols pour son utilisationdans le traitement d’une pathologie neuronale liée à une hypoxie et/ou à une hypoglycémie et composition correspondante |
| US11174220B2 (en) | 2019-12-13 | 2021-11-16 | Inspirna, Inc. | Metal salts and uses thereof |
| BE1028852B1 (fr) * | 2020-12-03 | 2022-07-05 | Dendrogenix | PRODROGUE DU 5α-hydroxy-6β-[2-(1H-imidazol-4-yl) éthylamino]cholestan-3β-ol ET COMPOSITIONS PHARMACEUTIQUES LE COMPRENANT POUR UTILISATION DANS LE TRAITEMENT DU CANCER |
| AU2021372797A1 (en) * | 2020-10-29 | 2023-06-15 | Dendrogenix | 5alpha-hydroxy-6beta-[2-(1-h-imidazol-4-yl)-ethylamino]-cholestan-3beta-ol analogues and pharmaceutical compositions comprising same for use in the treatment of cancer |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2838741B1 (fr) | 2002-04-19 | 2006-01-27 | Inst Nat Sante Rech Med | Derives de sterols, leur procede de preparation et medicaments les comportant |
-
2012
- 2012-11-23 EP EP12788589.5A patent/EP2782923B1/en active Active
- 2012-11-23 MX MX2014006303A patent/MX343787B/es active IP Right Grant
- 2012-11-23 KR KR1020147016187A patent/KR20140098131A/ko not_active Withdrawn
- 2012-11-23 ES ES12788589.5T patent/ES2613753T3/es active Active
- 2012-11-23 JP JP2014542857A patent/JP6157492B2/ja active Active
- 2012-11-23 IN IN976MUN2014 patent/IN2014MN00976A/en unknown
- 2012-11-23 CA CA2856609A patent/CA2856609C/en active Active
- 2012-11-23 BR BR112014012458A patent/BR112014012458A2/pt not_active IP Right Cessation
- 2012-11-23 AU AU2012342460A patent/AU2012342460B2/en active Active
- 2012-11-23 RU RU2014125435/04A patent/RU2014125435A/ru not_active Application Discontinuation
- 2012-11-23 WO PCT/EP2012/073489 patent/WO2013076257A1/en not_active Ceased
- 2012-11-23 CN CN201280065737.0A patent/CN104039807B/zh active Active
- 2012-11-23 US US14/359,658 patent/US9447141B2/en active Active
-
2014
- 2014-05-22 ZA ZA2014/03736A patent/ZA201403736B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| US9447141B2 (en) | 2016-09-20 |
| MX343787B (es) | 2016-10-31 |
| CN104039807A (zh) | 2014-09-10 |
| EP2782923A1 (en) | 2014-10-01 |
| AU2012342460A1 (en) | 2014-06-12 |
| EP2782923B1 (en) | 2016-11-23 |
| JP6157492B2 (ja) | 2017-07-05 |
| WO2013076257A1 (en) | 2013-05-30 |
| CA2856609C (en) | 2021-01-12 |
| KR20140098131A (ko) | 2014-08-07 |
| AU2012342460B2 (en) | 2017-06-29 |
| IN2014MN00976A (cg-RX-API-DMAC10.html) | 2015-04-24 |
| JP2015502934A (ja) | 2015-01-29 |
| ES2613753T3 (es) | 2017-05-25 |
| CN104039807B (zh) | 2018-02-13 |
| MX2014006303A (es) | 2014-09-08 |
| BR112014012458A2 (pt) | 2017-06-06 |
| ZA201403736B (en) | 2015-11-25 |
| US20140309417A1 (en) | 2014-10-16 |
| CA2856609A1 (en) | 2013-05-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2014125435A (ru) | Способ получения производных стерина | |
| CN103384641B (zh) | 含氟磺酰亚胺盐的制造方法 | |
| CN103980315B (zh) | 含三嗪环的磷-氮-硅化合物及其制备方法 | |
| JP2020523378A5 (cg-RX-API-DMAC10.html) | ||
| RU2014117188A (ru) | Способ получения производных 4,4-дифтор-3,4-дигидроизохинолина | |
| RU2010138813A (ru) | Безгалогеновые основанные на безоксазине отверждаемые композиции с высокой температурой стеклования | |
| RU2009105669A (ru) | Способ получения 3-замещенных 2-амино-5-галогенбензамидов | |
| JP2011514884A5 (cg-RX-API-DMAC10.html) | ||
| RU2010141941A (ru) | Способ получения фторсодержащего производного ацилуксусной кислоты, способ получения фторсодержащего производного сложного эфира пиразолкарбоновой кислоты и способ получения фторсодержащего пиразолкарбоновой кислоты | |
| JP2013518945A5 (cg-RX-API-DMAC10.html) | ||
| RU2013107023A (ru) | Способ получения производных аминобензоилбензофурана | |
| MY150973A (en) | Method for producing diamine derivative | |
| TW201226414A (en) | Thioether-containing alkoxysilane derivative and use thereof | |
| NZ604176A (en) | Method for manufacturing of quinoline-3-carboxamides | |
| RU2017144050A (ru) | Способ синтеза производных рапамицина | |
| EA201200282A1 (ru) | Региоселективное получение производных 2-амино-5-трифторметилпиримидина | |
| RU2020108470A (ru) | Аддитивная композиция для культуральной среды, аддитивное соединение для культуральной среды и способ культивирования клеток или тканей с использованием этой композиции и соединения | |
| AR091075A1 (es) | Proceso para preparar derivados monociclicos de heteroaril-cicloalquil-diamina | |
| MX2010006446A (es) | Nuevos derivados de diazeniodiolato, procedimiento para la preparacion de los mismos y composiciones farmaceuticas que los contienen. | |
| JP2018502174A5 (cg-RX-API-DMAC10.html) | ||
| RU2012145738A (ru) | Способ получения кремнийсодержащих азодикарбамидов | |
| JP2013543530A5 (cg-RX-API-DMAC10.html) | ||
| RU2012142223A (ru) | Пространственно-затрудненные амины | |
| RU2010150483A (ru) | Аддукты фуллерена и способ их получения | |
| JP2015512381A5 (cg-RX-API-DMAC10.html) |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA92 | Acknowledgement of application withdrawn (lack of supplementary materials submitted) |
Effective date: 20180312 |